Kaye Biotech Inc. had the following equity account balances at December 31, 2022: Preferred shares, $ 2.95, non-cumulative, Authorized: 22,000 shares Issued and outstanding: 6,000 shares $ 42,000 Common shares, Authorized: Unlimited Issued and outstanding: 90,000 shares 304, 618 Retained earnings 44,600 On February 1, 2023, 6,000 preferred shares were issued at $8.70 each. The board of directors declared and paid the annual cash dividend on the preferred shares on June 30, 2023, and a 13% common share dividend was declared and distributed on the same day when the market price per common share was $4.70. On October 1, 2023, 22,000 common shares were issued at $4.84 each. Profit earned during 2023 was $418,800. Required: Using the information provided, prepare the statement of changes in equity for the year ended December 31, 2023. (Amounts to be deducted should be indicated by a minus sign.)

Intermediate Accounting: Reporting And Analysis
3rd Edition
ISBN:9781337788281
Author:James M. Wahlen, Jefferson P. Jones, Donald Pagach
Publisher:James M. Wahlen, Jefferson P. Jones, Donald Pagach
Chapter16: Retained Earnings And Earnings Per Share
Section: Chapter Questions
Problem 18E: Monona Company reported net income of 29,975 for 2019. During all of 2019, Monona had 1,000 shares...
icon
Related questions
Question
None
Kaye Biotech Inc. had the following equity account
balances at December 31, 2022: Preferred shares, $
2.95, non cumulative, Authorized: 22,000 shares
Issued and outstanding: 6,000 shares $ 42,000
Common shares, Authorized: Unlimited Issued and
outstanding: 90,000 shares 304, 618 Retained earnings
44,600 On February 1, 2023, 6,000 preferred shares
were issued at $8.70 each. The board of directors
declared and paid the annual cash dividend on the
preferred shares on June 30, 2023, and a 13% common
share dividend was declared and distributed on the
same day when the market price per common share
was $4.70. On October 1, 2023, 22,000 common
shares were issued at $4.84 each. Profit earned during
2023 was $418,800. Required: Using the information
provided, prepare the statement of changes in equity
for the year ended December 31, 2023. (Amounts to
be deducted should be indicated by a minus sign.)
Transcribed Image Text:Kaye Biotech Inc. had the following equity account balances at December 31, 2022: Preferred shares, $ 2.95, non cumulative, Authorized: 22,000 shares Issued and outstanding: 6,000 shares $ 42,000 Common shares, Authorized: Unlimited Issued and outstanding: 90,000 shares 304, 618 Retained earnings 44,600 On February 1, 2023, 6,000 preferred shares were issued at $8.70 each. The board of directors declared and paid the annual cash dividend on the preferred shares on June 30, 2023, and a 13% common share dividend was declared and distributed on the same day when the market price per common share was $4.70. On October 1, 2023, 22,000 common shares were issued at $4.84 each. Profit earned during 2023 was $418,800. Required: Using the information provided, prepare the statement of changes in equity for the year ended December 31, 2023. (Amounts to be deducted should be indicated by a minus sign.)
Expert Solution
steps

Step by step

Solved in 3 steps

Blurred answer
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Intermediate Accounting: Reporting And Analysis
Intermediate Accounting: Reporting And Analysis
Accounting
ISBN:
9781337788281
Author:
James M. Wahlen, Jefferson P. Jones, Donald Pagach
Publisher:
Cengage Learning
Excel Applications for Accounting Principles
Excel Applications for Accounting Principles
Accounting
ISBN:
9781111581565
Author:
Gaylord N. Smith
Publisher:
Cengage Learning
College Accounting, Chapters 1-27 (New in Account…
College Accounting, Chapters 1-27 (New in Account…
Accounting
ISBN:
9781305666160
Author:
James A. Heintz, Robert W. Parry
Publisher:
Cengage Learning
Financial Accounting Intro Concepts Meth/Uses
Financial Accounting Intro Concepts Meth/Uses
Finance
ISBN:
9781285595047
Author:
Weil
Publisher:
Cengage
Cornerstones of Financial Accounting
Cornerstones of Financial Accounting
Accounting
ISBN:
9781337690881
Author:
Jay Rich, Jeff Jones
Publisher:
Cengage Learning
Principles of Accounting Volume 1
Principles of Accounting Volume 1
Accounting
ISBN:
9781947172685
Author:
OpenStax
Publisher:
OpenStax College